Common Side Effects Patients Report with Humira
Humira (adalimumab), a TNF blocker for autoimmune conditions like rheumatoid arthritis and Crohn's disease, often causes injection-site reactions such as redness, itching, pain, or swelling—these affect over 10% of users in clinical trials.[1] Upper respiratory infections, headaches, and rash occur frequently, along with nausea and sinusitis.[1][2]
Serious Risks and FDA Black-Box Warnings
Humira carries warnings for increased infection risk, including tuberculosis reactivation and serious infections like sepsis or fungal infections—fatal cases have occurred.[1] It raises lymphoma and other cancer risks, especially in children and those with prior exposure.[1] Heart failure can worsen, and patients face higher chances of lupus-like symptoms or nervous system issues like multiple sclerosis-like demyelination.[2]
What Happens with Long-Term Use?
Over time, users report higher rates of serious infections (up to 4% in trials) and malignancies (0.7% in rheumatoid arthritis studies).[1] Liver enzyme elevations and blood disorders like pancytopenia also emerge, sometimes requiring discontinuation.[2]
Side Effects in Specific Conditions Like Psoriasis or IBD
In psoriasis trials, more skin infections and headaches appear; for inflammatory bowel disease, abdominal pain and worsening colitis are noted.[1] Pediatric patients see similar profiles but with growth suppression risks.[2]
How Do Patients Manage or Report These?
Many experience mild effects that fade, but doctors screen for TB and monitor bloodwork before and during treatment. Report severe symptoms like persistent fever or unexplained bruising to the FDA via MedWatch.[1] Biosimilars like Amjevita share comparable risks.[3]
Sources
[1]: Humira Prescribing Information (FDA)
[2]: Drugs.com - Humira Side Effects
[3]: DrugPatentWatch.com - Humira Patents and Biosimilars